Literature DB >> 21013252

Studies on synthetic antimalarial drugs; some biguanide derivatives as new types of antimalarial substances with both therapeutic and causal prophylactic activity.

F H S CURD, D G DAVEY, F L ROSE.   

Abstract

Entities:  

Keywords:  GUANIDINE/therapy; MALARIA/therapy

Mesh：

Substances：

Year:  1945        PMID： 21013252

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  7 in total

1.  Metformin: historical overview.

Authors:  Clifford J Bailey
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

2.  A new bis-guanylhydrazone with antileukemic properties.

Authors:  A Marxer
Journal:  Experientia       Date:  1967-03-15

Review 3.  Metformin and Cancer, an Ambiguanidous Relationship.

Authors:  Sarah J Skuli; Safwan Alomari; Hallie Gaitsch; A'ishah Bakayoko; Nicolas Skuli; Betty M Tyler
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-19

Review 4.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 5.  Biguanide is a modifiable pharmacophore for recruitment of endogenous Zn2+ to inhibit cysteinyl cathepsins: review and implications.

Authors:  Thomas D Lockwood
Journal:  Biometals       Date:  2019-05-01       Impact factor: 2.949

Review 6.  Re-Envisioning Anti-Apicomplexan Parasite Drug Discovery Approaches.

Authors:  Gabriel W Rangel; Manuel Llinás
Journal:  Front Cell Infect Microbiol       Date:  2021-06-11       Impact factor: 5.293

7.  Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer.

Authors:  Snehal K Shukla; Nishant S Kulkarni; Amanda Chan; Vineela Parvathaneni; Pamela Farrales; Aaron Muth; Vivek Gupta
Journal:  Pharmaceutics       Date:  2019-10-28       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.